About Picterus
Changing the Story of Jaundice Care
Founded in 2015 in Trondheim, Norway, Picterus is a medical technology company with a global reach. We develop scalable, research-based solutions to improve newborn care — starting with neonatal jaundice, which affects the majority of newborns worldwide.
Our commitment extends beyond country borders, striving to elevate the standards of jaundice care globally. The strength of our work lies in extensive research and innovation, resulting in a portfolio of patents and the CE-certification of our app as a class IIa medical device.
Designed for both healthcare professionals and parents, our solution makes early detection more accessible than ever — anywhere in the world.
Picterus Jaundice Pro - More than just an app
Our journey to saving newborns’ lives worldwide, one baby at a time.
2012 - 2016
Concept & feasibility research
2017 - 2020
Clinical validation and patented technology
2021 - 2022
First CE‑marked medical device
2023 - 2024
Expanded clinical use and usability improvements
2025 - Present
Next‑generation model & broader inclusivity
-
best performance to date
Our Mission
Picterus is dedicated to revolutionizing neonatal jaundice care by offering a universally accessible and accurate screening solution, ensuring a healthy start for every child, anywhere and anytime.
Picterus Newborn Health:
Bridging the Gap
To extend our impact, we established Picterus Newborn Health in 2025 — a nonprofit organization committed to advancing global equity in newborn care. Focused on jaundice awareness, education, and access to care, the organization works closely with local communities, partners, and governments to deliver screening solutions to newborns in low-resource settings.
Together with parents, healthcare providers, and partners around the world, we’re moving closer to the goal of giving every baby the best start in life.
Donate and help us reach even more newborns